English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The objective was to define features of comorbidity in patients with type 2 diabetes, to estimate a possibility of use of comorbidity indices in the management of these patients. Materials and methods. Patients with type 2 diabetes participated in the study. The retrospective analysis of medical records with calculation of comorbidity indices using CIRS, Kaplan-Feinstein and Charlson systems was made. Taking into account the received indices, prognostic indicators of mortality risk (%) within the next year and 10-year survival were defined. Correlation between laboratory metabolic syndrome parameters and values of comorbidity indices were defined. Results. It was defined that in structure of comorbidity in studied patients cardiovascular, nervous and genitourinary disorders prevailed. Besides the specified systems, in women the proportion of endocrine pathology was high. With age, there is a tendency to the prevalence of comorbid pathology of these systems, as well as an increase in the average score of the comorbidity indices for all systems and deterioration in prognostic indicators are revealed. Statistically significant direct link between comorbidity indices and certain components of metabolic syndrome, and with the disease duration was also detected.

STUDYING OF COMORBID PATHOLOGY AT THE 2 TYPES DIABETES AS THE COMPLICATION OF THE METABOLIC SYNDROME